0

Journal Articles

in Psychopharmacology
 21-40 of 34 Articles
Original Article |  August 01, 2009 FREE
A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression:  The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
Barnett S. Meyers, MD; Alastair J. Flint, MD; Anthony J. Rothschild, MD; et al.
Arch Gen Psychiatry. 2009;66(8):838-847. doi:10.1001/archgenpsychiatry.2009.79.
Original Article |  December 01, 2006 FREE
Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major Depression:  A Multisite Study From the Consortium for Research in Electroconvulsive Therapy (CORE)
Charles H. Kellner, MD; Rebecca G. Knapp, PhD; Georgios Petrides, MD; et al.
Arch Gen Psychiatry. 2006;63(12):1337-1344. doi:10.1001/archpsyc.63.12.1337.
Original Article |  August 01, 2005 FREE
Cost-effectiveness of Evidence-Based Pharmacotherapy or Cognitive Behavior Therapy Compared With Community Referral for Major Depression in Predominantly Low-Income Minority Women
Dennis A. Revicki, PhD; Juned Siddique, MS; Lori Frank, PhD; et al.
Arch Gen Psychiatry. 2005;62(8):868-875. doi:10.1001/archpsyc.62.8.868.
Original Article |  June 01, 2005 FREE
Cognitive Modulation of the Endocrine Stress Response to a Pharmacological Challenge in Normal and Panic Disorder Subjects
James L. Abelson, MD, PhD; Israel Liberzon, MD; Elizabeth A. Young, MD; et al.
Arch Gen Psychiatry. 2005;62(6):668-675. doi:10.1001/archpsyc.62.6.668.
Original Article |  April 01, 2005 FREE
Impact of 3-Tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children
Haiden A. Huskamp, PhD; Patricia A. Deverka, MD, MS; Arnold M. Epstein, MD, MA; et al.
Arch Gen Psychiatry. 2005;62(4):435-441. doi:10.1001/archpsyc.62.4.435.
Original Article |  July 01, 2004 FREE
Combined Pharmacotherapy and Psychological Treatment for Depression:  A Systematic Review
Sandro Pampallona, ScD; Paola Bollini, MD, DrPH; Giuseppe Tibaldi, MD; et al.
Arch Gen Psychiatry. 2004;61(7):714-719. doi:10.1001/archpsyc.61.7.714.
Original Article |  February 01, 2004 FREE
Pharmacotherapy Plus Psychotherapy for Treatment of Depression in ActiveInjection Drug Users
Michael D. Stein, MD; David A. Solomon, MD; Debra S. Herman, PhD; et al.
Arch Gen Psychiatry. 2004;61(2):152-159. doi:10.1001/archpsyc.61.2.152.
Original Article |  September 01, 2003 FREE
A Randomized Study of Family-Focused Psychoeducation and Pharmacotherapy in the Outpatient Management of Bipolar Disorder
David J. Miklowitz, PhD; Elizabeth L. George, PhD; Jeffrey A. Richards, MA; et al.
Arch Gen Psychiatry. 2003;60(9):904-912. doi:10.1001/archpsyc.60.9.904.
Commentary |  March 01, 2002
Out of the Box
Alan J. Gelenberg, MD
Arch Gen Psychiatry. 2002;59(3):281. doi:10.1001/archpsyc.59.3.281.
Perspectives |  March 01, 2002
Improving Clinical Trials:  American Society of Clinical Psychopharmacology Recommendations
Donald F. Klein, MD; Michael E. Thase, MD; Jean Endicott, PhD; et al.
Arch Gen Psychiatry. 2002;59(3):272-278. doi:10.1001/archpsyc.59.3.272.
Commentary |  June 01, 2001
Sex and Psychopharmacology:  Is Natural Estrogen a Psychotropic Drug in Women?
Stephen M. Stahl, MD, PhD
Arch Gen Psychiatry. 2001;58(6):537-538. doi:10.1001/archpsyc.58.6.537.
Commentary |  April 01, 2000
What Conditions Are Necessary to Assess Antidepressant Efficacy?
Frederic M. Quitkin, MD; Donald F. Klein, MD
Arch Gen Psychiatry. 2000;57(4):323-324. doi:10.1001/archpsyc.57.4.323.
Commentary |  November 01, 1999
Treating Imagined Ugliness
Katharine A. Phillips, MD; Steven A. Rasmussen, MD; Lawrence H. Price, MD
Arch Gen Psychiatry. 1999;56(11):1041-1042. doi:10.1001/archpsyc.56.11.1041.
Perspectives |  December 01, 1998
Treating Major Depression in Primary Care Practice:  An Update of the Agency for Health Care Policy and Research Practice Guidelines
Herbert C. Schulberg, PhD; Wayne Katon, MD; Gregory E. Simon, MD; et al.
Arch Gen Psychiatry. 1998;55(12):1121-1127. doi:10.1001/archpsyc.55.12.1121.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 29, 2013
Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery
Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; et al.
JAMA Internal Medicine
Invited Commentary  |  April 29, 2013
Selective Serotonin Reuptake Inhibitors and Surgery: To Hold or Not to Hold, That Is the Question:  Comment on “Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery”
Marko Mrkobrada, MD, FRCPC; Daniel G. Hackam, MD, PhD, FRCPC
JAMA Internal Medicine
Review Article  |  March 4, 2013
Pharmacologic Therapy for Primary Restless Legs Syndrome:  A Systematic Review and Meta-analysis
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA
Original Contribution  |  April 03, 2013
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy:  A Randomized Clinical Trial
Ellen M. Lavoie Smith, PhD; Herbert Pang, PhD; Constance Cirrincione, MS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems